StockNews.com initiated coverage on shares of Veradigm (NASDAQ:MDRX – Free Report) in a research note released on Wednesday morning. The brokerage issued a hold rating on the software maker’s stock.
Separately, Stephens increased their price target on Veradigm from $7.00 to $13.00 and gave the stock an “equal weight” rating in a report on Friday, January 31st.
Check Out Our Latest Stock Analysis on MDRX
Veradigm Trading Up 7.0 %
About Veradigm
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Read More
- Five stocks we like better than Veradigm
- Basic Materials Stocks Investing
- IBM’s AI Bet Pays Off—What’s Next for Investors?
- What Does a Stock Split Mean?
- 3 Reasons to Treat AMD’s Drop as an Entry Opportunity
- The Risks of Owning Bonds
- Qualcomm’s Post-Earnings Dip: A Prime Buying Opportunity?
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
